| Source HCPCS Code |
|
Target NDC Code |
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00078-0675-15
ZOFRAN 4 MG
|
| Detail Information |
| Relationship Start Date |
03/20/2018 |
| Relationship End Date |
12/14/2021 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00078-0676-15
ZOFRAN (FILM COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/11/2018 |
| Relationship End Date |
09/29/2020 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00078-0679-19
ZOFRAN ODT (3X10) 4 MG
|
| Detail Information |
| Relationship Start Date |
8/30/2017 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
ST |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00078-0680-19
ZOFRAN ODT 8 MG
|
| Detail Information |
| Relationship Start Date |
9/19/2017 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
ST |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
00093-0233-33
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
00093-0233-56
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
00093-0233-93
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
00093-7236-33
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00093-7236-56
ONDANSETRON HYDROCHLORIDE (FILM COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
10/5/2016 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
00093-7236-93
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
00093-7301-65
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00093-7302-03
ONDANSETRON (USP,STRAWBERRY) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
00093-7302-65
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
00143-2422-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
00143-2422-30
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00143-2423-30
ONDANSETRON HYDROCHLORIDE (COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
4/10/2012 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00173-0446-00
ZOFRAN 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
00173-0446-02
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00173-0446-04
ZOFRAN (1X3 DAILY PACK) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00173-0447-00
ZOFRAN 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
02/29/2020 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00173-0447-02
ZOFRAN 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
8/21/2013 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00173-0447-04
ZOFRAN (1X3 DAILY PACK) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
4/1/2014 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00173-0489-00
ZOFRAN (BERRY) 4 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00173-0569-00
ZOFRAN ODT 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
8/29/2017 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00173-0570-00
ZOFRAN ODT 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
9/18/2017 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
00173-0570-04
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00378-0315-53
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00378-0315-93
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
01/31/2020 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00378-0344-53
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00378-0344-93
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
01/31/2020 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00378-7732-93
ONDANSETRON (USP) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
05/31/2024 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00378-7734-93
ONDANSETRON (USP) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
05/31/2024 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00378-7734-97
ONDANSETRON (USP) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
05/31/2024 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00490-0075-00
ONDANSETRON ODT 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00490-0075-30
ONDANSETRON ODT 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00490-0075-60
ONDANSETRON ODT 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00490-0075-90
ONDANSETRON ODT 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
00781-1679-31
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
00781-1679-33
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00781-1681-31
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
11/30/2019 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
00781-1681-33
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00781-5238-64
ONDANSETRON (USP,3X10,STRAWBERRY) 4 MG
|
| Detail Information |
| Relationship Start Date |
12/18/2008 |
| Relationship End Date |
11/30/2020 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
00781-5239-64
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
00781-5239-80
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00781-5257-13
ONDANSETRON HYDROCHLORIDE (FILM COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00781-5257-31
ONDANSETRON HYDROCHLORIDE (FILM COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00781-5257-33
ONDANSETRON HYDROCHLORIDE (FILM COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00781-5258-13
ONDANSETRON HYDROCHLORIDE (FILM COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00781-5258-31
ONDANSETRON HYDROCHLORIDE (FILM COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMENONDANSETRON HYDROCHLORIDE (FILM COATED) 8 MG
|
⇄
|
00781-5258-33
ONDANSETRON HYDROCHLORIDE (FILM COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00781-5265-64
ONDANSETRON (3X10,STRAWBERRY) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00781-5266-64
ONDANSETRON (3X10,STRAWBERRY) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00781-5266-80
ONDANSETRON (1X10,STRAWBERRY) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
00904-7073-93
ONDANSETRON 4 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
11/30/2020 |
| Relationship End Date |
08/05/2024 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
CP |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16714-0159-01
ONDANSETRON HCL (USP,FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
08/18/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16714-0160-01
ONDANSETRON HCL (USP,FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
08/18/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16714-0200-30
ONDANSETRON (USP,3X10) 4 MG
|
| Detail Information |
| Relationship Start Date |
08/18/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16714-0201-10
ONDANSETRON (USP,STRAWBERRY GUARANA) 8 MG
|
| Detail Information |
| Relationship Start Date |
08/18/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16714-0201-30
ONDANSETRON (USP,3X10) 8 MG
|
| Detail Information |
| Relationship Start Date |
08/18/2021 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
16714-0671-01
ONDANSETRON (USP,1X60ML,STRAWBERRY) 4 MG/5ML
|
| Detail Information |
| Relationship Start Date |
10/15/2009 |
| Relationship End Date |
10/31/2016 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
33358-0369-02
ZOFRAN 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
04/01/2020 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
33358-0370-02
ZOFRAN 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
04/01/2020 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
42291-0457-30
Ondansetron STRAWBERRY 4 MG
|
| Detail Information |
| Relationship Start Date |
05/15/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
42291-0458-30
Ondansetron STRAWBERRY 8 MG
|
| Detail Information |
| Relationship Start Date |
05/15/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
45802-0127-14
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
45802-0127-65
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
45802-0205-14
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
45802-0205-65
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
45963-0539-30
ONDANSETRON (USP,FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
08/29/2011 |
| Relationship End Date |
10/21/2024 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
49999-0783-30
ZOFRAN (CAPLET) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
50111-0819-42
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
50268-0647-14
ONDANSETRON AVPAK 4 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
09/20/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
50436-1880-01
ONDANSETRON HYDROCHLORIDE 8 MG
|
| Detail Information |
| Relationship Start Date |
12/04/2018 |
| Relationship End Date |
12/31/2022 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51079-0524-01
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
09/30/2019 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51079-0524-20
ONDANSETRON HYDROCHLORIDE (USP,10X10,FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
09/30/2019 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51079-0525-01
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
04/30/2019 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51079-0525-20
ONDANSETRON HYDROCHLORIDE (USP,10X10,FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
04/30/2019 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51407-0003-05
ONDANSETRON FILM-COATED 4 MG
|
| Detail Information |
| Relationship Start Date |
01/07/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BT |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51407-0003-30
ONDANSETRON FILM-COATED 4 MG
|
| Detail Information |
| Relationship Start Date |
01/08/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BT |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51407-0004-05
ONDANSETRON FILM-COATED 8 MG
|
| Detail Information |
| Relationship Start Date |
01/07/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BT |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51407-0004-30
ONDANSETRON FILM-COATED 8 MG
|
| Detail Information |
| Relationship Start Date |
01/08/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BT |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
51672-4091-03
ONDANSETRON HYDROCHLORIDE (1x50ML) 4MG/5ML
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52152-0538-30
ONDANSETRON HYDROCHLORIDE, (FILM-COATED), 4 MG
|
| Detail Information |
| Relationship Start Date |
7/10/2012 |
| Relationship End Date |
7/11/2012 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
52152-0539-30
ONDANSETRON HYDROCHLORIDE, (FILM-COATED), 8 MG
|
| Detail Information |
| Relationship Start Date |
7/10/2012 |
| Relationship End Date |
7/11/2012 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54569-5873-00
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
4 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
54569-5873-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-3508-00
ZOFRAN (1X3 DAILY PACK) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-3508-01
ZOFRAN 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-3508-02
ZOFRAN 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-3509-00
ZOFRAN (1X3 DAILY PACK) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-3509-01
ZOFRAN 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-3509-02
ZOFRAN 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-3509-03
ZOFRAN 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5089-00
ZOFRAN ODT 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
2 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5089-01
ZOFRAN ODT 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5089-02
ZOFRAN ODT 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5089-03
ZOFRAN ODT 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5089-04
ZOFRAN ODT 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
20 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5089-05
ZOFRAN ODT 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
2/3/2016 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5738-00
ONDANSETRON HYDROCHLORIDE 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5749-00
ONDANSETRON ODT 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5749-01
ONDANSETRON ODT 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5801-00
ONDANSETRON 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5801-01
ONDANSETRON 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
15 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
54868-5887-00
ONDANSETRON (STRAWBERRY) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-3729-03
ONDANSETRON HYDROCHLORIDE 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55045-3815-01
ONDANSETRON 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55111-0153-13
ONDANSETRON HYDROCHLORIDE (1X3,FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55111-0153-30
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55111-0154-13
ONDANSETRON HYDROCHLORIDE (1X3,FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55111-0154-30
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55111-0156-11
ONDANSETRON HYDROCHLORIDE (1X1,FILM-COATED) 24 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55289-0559-03
ONDANSETRON (USP,STRAWBERRY) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55289-0559-05
ONDANSETRON (STRAWBERRY) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
55289-0559-06
ONDANSETRON (USP,STRAWBERRY) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
6 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57237-0075-30
ONDANSETRON HCL (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
04/01/2016 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57237-0075-50
ONDANSETRON HCL (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
11/07/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57237-0076-30
ONDANSETRON HCL (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
04/01/2016 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57237-0076-50
ONDANSETRON HCL (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
11/07/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57237-0077-30
ONDANSETRON (USP,STRAWBERRY GUARANA) 4 MG
|
| Detail Information |
| Relationship Start Date |
02/19/2016 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57237-0077-50
ONDANSETRON USP,STRAWBERRY GUARANA 4 MG
|
| Detail Information |
| Relationship Start Date |
10/21/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57237-0078-30
ONDANSETRON (USP,STRAWBERRY GUARANA) 8 MG
|
| Detail Information |
| Relationship Start Date |
02/19/2016 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
57237-0078-50
ONDANSETRON USP,STRAWBERRY GUARANA 8 MG
|
| Detail Information |
| Relationship Start Date |
10/21/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0084-00
ZOFRAN 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0084-10
ZOFRAN 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0084-30
ZOFRAN 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0084-60
ZOFRAN 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0084-90
ZOFRAN 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0826-00
ZOFRAN 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0826-30
ZOFRAN 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0826-60
ZOFRAN 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
60 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
58016-0826-90
ZOFRAN 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
90 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
59762-2990-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
59762-2990-02
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
59762-2993-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
59762-2993-02
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
60505-0381-05
ONDANSETRON (USP,1X50ML) 4 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
1/31/2014 |
| Number Of Items In Ndc Package |
1 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
60687-0252-86
ONDANSETRON 4 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
01/28/2019 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
CP |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0121-30
ONDANSETRON (STRAWBERRY) 4 MG
|
| Detail Information |
| Relationship Start Date |
03/30/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0122-30
ONDANSETRON (STRAWBERRY) 8 MG
|
| Detail Information |
| Relationship Start Date |
03/30/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0350-05
ONDANSETRON (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
04/20/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0350-30
ONDANSETRON (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
04/20/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0351-05
ONDANSETRON (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
04/20/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0351-30
ONDANSETRON (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
04/20/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0555-24
ONDANSETRON USP 4 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
08/28/2024 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62135-0555-58
ONDANSETRON (USP) 4 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
10/10/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
50 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62756-0130-01
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62756-0131-01
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62756-0240-64
ONDANSETRON 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
12/19/2022 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62756-0356-64
ONDANSETRON 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
12/19/2022 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
62756-0356-66
ONDANSETRON 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
12/19/2022 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63304-0458-30
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
63304-0459-30
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
65862-0187-03
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
65862-0187-05
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
65862-0187-30
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
65862-0188-03
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
65862-0188-05
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
|
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
65862-0188-30
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
65862-0390-10
ONDANSETRON (USP,3X10) 4 MG
|
| Detail Information |
| Relationship Start Date |
03/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
65862-0391-10
ONDANSETRON (USP,3X10) 8 MG
|
| Detail Information |
| Relationship Start Date |
03/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
66336-0268-03
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
66336-0793-03
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
1/1/2012 |
| Relationship End Date |
6/1/2014 |
| Number Of Items In Ndc Package |
3 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68001-0246-04
ONDANSETRON (USP,3X10,STRAWBERRY) 4 MG
|
| Detail Information |
| Relationship Start Date |
04/24/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
ST |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
68001-0246-17
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
68001-0247-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68001-0247-04
ONDANSETRON (USP, 3X10,STRAWBERRY) 8 MG
|
| Detail Information |
| Relationship Start Date |
04/24/2018 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
ST |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68001-0247-16
ONDANSETRON (STRAWBERRY) 8 MG
|
| Detail Information |
| Relationship Start Date |
03/13/2014 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BP |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
|
⇄
|
68001-0247-17
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
68084-0220-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
|
⇄
|
68084-0221-01
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68462-0105-30
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68462-0106-30
ONDANSETRON HYDROCHLORIDE (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68462-0157-13
ONDANSETRON (STRAWBERRY) 4 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68462-0158-11
ONDANSETRON (STRAWBERRY) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68462-0158-13
ONDANSETRON (STRAWBERRY) 8 MG
|
| Detail Information |
| Relationship Start Date |
01/01/2012 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
10 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
68999-0555-24
Ondansetron USP 4 MG/5 ML
|
| Detail Information |
| Relationship Start Date |
02/18/2026 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
BX |
| Route Of Administration |
PO |
| Billing Units |
ML |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
69339-0171-01
Ondansetron FILM-COATED 4 MG
|
| Detail Information |
| Relationship Start Date |
01/28/2026 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
69339-0171-03
ONDANSETRON HCL (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
10/24/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
69339-0171-05
ONDANSETRON HCL (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
07/24/2023 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
|
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
69339-0172-01
Ondansetron FILM-COATED 8 MG
|
| Detail Information |
| Relationship Start Date |
01/28/2026 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
100 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
69339-0172-03
ONDANSETRON (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
10/24/2022 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
71930-0017-30
ONDANSETRON HCL (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
07/18/2018 |
| Relationship End Date |
10/31/2024 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
71930-0017-52
ONDANSETRON HCL (FILM-COATED) 4 MG
|
| Detail Information |
| Relationship Start Date |
02/12/2020 |
| Relationship End Date |
10/31/2024 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
71930-0018-30
ONDANSETRON (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
07/18/2018 |
| Relationship End Date |
10/31/2024 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
71930-0018-52
ONDANSETRON (FILM-COATED) 8 MG
|
| Detail Information |
| Relationship Start Date |
02/12/2020 |
| Relationship End Date |
10/31/2024 |
| Number Of Items In Ndc Package |
500 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
83980-0012-13
ONDANSETRON STRAWBERRY 4 MG
|
| Detail Information |
| Relationship Start Date |
08/13/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
ONDANSETRON 1 MG, ORAL, FDA APPROVED PRESCRIPTION ANTI-EMETIC, FOR USE AS A COMPLETE THERAPEUTIC SUBSTITUTE FOR AN IV ANTI-EMETIC AT THE TIME OF CHEMOTHERAPY TREATMENT, NOT TO EXCEED A 48 HOUR DOSAGE REGIMEN
|
⇄
|
83980-0013-13
ONDANSETRON STRAWBERRY 8 MG
|
| Detail Information |
| Relationship Start Date |
08/13/2025 |
| Relationship End Date |
99/99/9999 |
| Number Of Items In Ndc Package |
30 |
| Ndc Package Measure |
EA |
| Ndc Package Type |
BO |
| Route Of Administration |
PO |
| Billing Units |
EA |
|
|
|
Q0162
Ondansetron oral
|
⇄
|
60687-0252-86
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68084-0220-01
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68084-0221-01
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1128-01
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1200-00
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1200-01
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1200-02
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1200-03
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1201-00
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1658-00
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1658-01
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1658-02
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1658-03
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1659-00
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1660-00
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1660-01
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1660-02
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-1660-03
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-2343-00
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-2343-01
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-2343-02
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-2343-03
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3178-00
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3178-01
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3178-02
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3178-04
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3178-05
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3185-00
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3185-01
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3185-02
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3185-03
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3185-04
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3769-00
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3769-01
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3769-03
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-3769-04
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-4632-00
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-4632-01
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-4632-02
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-4632-03
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-4671-00
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-4671-01
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-4671-02
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-4671-03
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-4671-04
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-5346-01
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-5346-02
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-5346-03
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-6342-00
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-6342-01
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-6342-02
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50090-6342-05
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50268-0621-15
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50268-0622-15
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
50268-0647-14
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68001-0246-04
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68001-0246-17
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68001-0247-04
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68001-0247-17
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
62135-0122-30
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
62135-0350-30
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
62135-0351-05
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
62135-0351-30
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
62135-0555-24
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
62135-0555-58
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
55111-0153-30
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
55111-0154-30
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68462-0105-30
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68462-0106-30
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68462-0157-13
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68462-0158-11
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68462-0158-13
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
72336-0073-30
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
00904-6551-61
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
00904-6552-61
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
16714-0159-01
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
16714-0160-01
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
16714-0200-30
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
16714-0201-10
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
16714-0201-30
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
16714-0671-02
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
43063-0792-06
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
43063-0857-02
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
43063-0857-04
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
43063-0857-05
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
43063-0857-06
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
43063-0857-10
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
43063-0857-20
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
43063-0870-04
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
43063-0870-10
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
72789-0034-12
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-7565-01
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-7565-03
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-7644-01
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-7644-03
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-8365-05
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-8582-01
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-8582-02
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-8582-03
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-8651-01
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-8651-02
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-8651-03
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-8651-05
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-8666-01
Ondansetron ODT
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-9368-01
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-9368-02
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-9368-03
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-9402-01
Ondansetron HCl
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|
Q0162
Ondansetron oral
|
⇄
|
68788-9402-03
Ondansetron
|
| Detail Information |
| Relationship Start Date |
|
| Relationship End Date |
|
| Number Of Items In Ndc Package |
|
| Ndc Package Measure |
|
| Ndc Package Type |
|
| Route Of Administration |
|
| Billing Units |
|
|
|
|